Carregant...
Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H
Hepatitis B virus (HBV) chronically infects >250 million people and kills nearly a million annually, and current antivirals cannot clear the infection or adequately suppress disease. The virus replicates by reverse transcription, and the dominant antiviral drugs are nucleos(t)ide analogs that tar...
Guardat en:
| Publicat a: | ACS Infect Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202671/ https://ncbi.nlm.nih.gov/pubmed/29565562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00045 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|